最近在治疗耐药结核病方面取得的进展和尚未满足的需求
Chiara Sepulcri1,2, Francesca Saluzzo2, Daniele Roberto Giacobbe1,3
1Department of Health Sciences, University of Genoa, Genova, Italy.
Expert review of clinical pharmacology
|December 18, 2025
概括
耐药结核病 (DR-TB) 治疗的进展提供了希望,但药物毒性和耐药性等挑战仍然存在. 新的口服治疗方案和诊断对于有效,公平的全球准入来打击这种健康威胁至关重要.
科学领域:
- 传染性疾病 传染性疾病
- 全球健康 全球健康
- 药理学 药理学是指药理学的学科.
背景情况:
- 耐药结核病 (DR-TB) 仍然是一个重大的全球卫生挑战.
- 最近的进展包括向更短,全口服治疗方案的转变.
- 然而,毒性,耐药性和公平获取等问题仍然存在.
研究的目的:
- 审查最近 (2020-2025) 关于新型耐药结核病治疗的文献.
- 确定DR-TB治疗中持续存在的挑战和新出现的解决方案.
- 突出综合药物诊断发展和公平获取的重要性.
主要方法:
- 在PubMed,Medline,Google Scholar,clinicaltrials.gov,世卫组织指南和会议摘要的文献搜索.
- 专注于新型DR-TB药物和治疗方案的II/III期临床试验.
- 试验数据,监测和实践研究对药物毒性和耐药性的审查.
主要成果:
- 简短的全口服治疗方案为DR-TB提供了新的治疗机会.
- 越来越多的贝达基林耐药性对目前的治疗疗效构成威胁.
- 新化合物的有希望的管道存在,但需要综合药物诊断开发.
结论:
- 尽管取得了进展,但药物毒性和耐药性仍然是DR-TB管理中的关键问题.
- 新的化合物和疗法显示出潜力,强调了联合药物诊断策略的必要性.
- 公平的全球获取先进的结核病治疗方法对于实现科学进步至关重要.
相关概念视频
Pulmonary Tuberculosis V
523
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
523
Pulmonary Tuberculosis I
802
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
802
Pulmonary Tuberculosis IV
468
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
468
Drug Therapy
232
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
232
Therapeutic Drug Monitoring: Affecting Factors
175
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
175
Development of Antibiotic Resistance
1.1K
Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
1.1K


